Skip to main content
OpenTrials

Clinical trial condition

Optic Nerve Diseases

Explore clinical trials studying Optic Nerve Diseases. Study availability and eligibility vary by location and protocol.

375 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Optic Nerve Diseases trial results

Completed

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

NCT02028884

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Hopital de Hautepierre CHRU de Strasbourg Strasbourg, France
  • NeuroCure Clinical Research Center (NCRC) Berlin, Germany
  • St. Josef-Hospital, Klinik für Neurologie Bochum, Germany
View all 40 locations
View Trial Details
Completed

An Open Label Study of the Effects of SHR1459 in NMOSDs Patients

NCT04670770

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +10 more
Locations
  • Xiangya Hospital Of Central South University Changsha, China
  • West China Hospital Sichuan University Chengdu, China
  • Lanzhou University Second Hospital Lanzhou, China
  • People's Hospital of Rizhao Rizhao, China
View Trial Details
Completed

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT02073279

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • University of Colorado Denver -; Neurology Aurora, Colorado, United States
  • University of Miami UHealth Professional Arts Center Miami, Florida, United States
  • The MS Center of Vero Beach Vero Beach, Florida, United States
  • Columbus Research and Wellness Columbus, Georgia, United States
View all 58 locations
View Trial Details
Completed

An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients

NCT02003144

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +26 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • The Research Center of Southern California Oceanside, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Miami McKnight Brain Institute Miami, Florida, United States
View all 69 locations
View Trial Details
Completed

Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

NCT02415153

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +33 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View Trial Details

Related conditions